Position in CCCC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$14,159,720
+$9,131,726 QoQ
Shares Held
3,032,060
+58.6% QoQ
Ownership
2.46%
of shares outstanding
% of Portfolio
1.58%
of 13F equity value
Holder Rank
#14
of 147 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Derivatives in CCCC
reported options exposure · as of Sep 30, 2024CallValue
$855,000
CallShares
150,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SILVERARC CAPITAL MANAGEMENT, LLC holds $802,586,993 across 53 Biotechnology names. CCCC ranks #19 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
206,234 | $55,006,732 | |
| 2 | CELC |
Celcuity Inc.
|
500,996 | $52,414,201 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
1,280,707 | $49,563,360 | |
| 4 | URGN |
UroGen Pharma Ltd.
|
1,301,979 | $47,912,827 | |
| 5 | IMNM |
Immunome Inc.
|
2,017,009 | $42,740,420 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
390,000 | $38,017,200 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
311,461 | $34,581,514 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
352,802 | $33,576,166 |
All Filings in CCCC
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,159,720 | 3,032,060 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,027,994 | 1,911,785 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,808,967 | 1,994,224 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,212,190 | 1,897,383 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $1,411,680 | 882,300 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,396,071 | 1,221,131 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $855,000 | 150,000 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $6,542,978 | 1,147,891 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,665,925 | 1,442,841 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,731,556 | 1,435,931 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||